CELSUS THERAPEUTICS PLC - 15119A202

Sector: No information yet · Industry: No information yet
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q1 2014
Value (USD)
Total reported value ($000)
$12.9M
QoQ value delta ($000)
Shares
Total shares
1,987,326
QoQ shares delta
Total shares held by funds (by quarter)

Top holders (Q1 2014)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
BAKER BROS. ADVISORS LP 4,374 673,887 0.06%
SABBY MANAGEMENT, LLC 4,342 669,080 0.24%
Broadfin Capital, LLC 3,056 470,877 0.3%
Cormorant Asset Management, LLC 668 103,000 0.15%
DAFNA Capital Management LLC 285 43,900 0.24%
Knoll Capital Management, LP 151 23,255 0.08%
CITIGROUP INC 16 2,460 0.0%
UBS AG 3 395 0.0%
Tower Research Capital LLC 3 465 0.0%
MORGAN STANLEY 0 7 0.0%